Starting today Biognosys and Waters Corporation enter into a co-marketing agreement. The combined use of the Biognosys Spectronaut™ Pulsar software and the Waters® SONAR™ data acquisition technology provides a comprehensive, efficient workflow for data-independent acquisition (DIA) mass spectrometry-based proteomics studies.
DIA is the gold standard for reproducible and highly-selective mass spectrometry-based proteomics. Using Spectronaut Pulsar for DIA, researchers can reproducibly and accurately quantify thousands of proteins in a single run. Coupled with the Waters SONAR technology, which enables quantification and identification of proteins in complex samples from a single injection without additional method development and repetitive assays, the combined workflow promises the generation of higher quality data when analyzing complex biological samples.
”SONAR technology tightly links two loosely connected dimensions of DIA data which makes this acquisition strategy very interesting. Expanding the functionality of Spectronaut Pulsar software to support SONAR data was the most logical step during development. It enables our users to achieve a higher level of data confidence even when analyzing complex samples,” said Lukas Reiter, Chief Technology Officer at Biognosys.
More information about the co-marketing agreement are available in the press release (click for download).